申请人:Fibrogen, Inc.
公开号:US08217043B2
公开(公告)日:2012-07-10
The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF) by inhibiting the activity of at least one HIF hydroxylase enzyme.
本发明涉及一种新型化合物,能够通过抑制至少一种HIF羟化酶酶活性来调节缺氧诱导因子(HIF)的稳定性和/或活性。